What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Asthma
Asthma, Internal medicine, Immunology, Genetics and Physical therapy are his primary areas of study.
His research in Asthma is mostly focused on Exhaled nitric oxide.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Placebo and Endocrinology.
His Placebo research incorporates elements of Benralizumab, Reslizumab, Surgery and Intention-to-treat analysis.
Eugene R. Bleecker has researched Immunology in several fields, including Sputum and Allele.
His Physical therapy research is multidisciplinary, incorporating perspectives in Body mass index, Randomized controlled trial, Intensive care medicine, COPD and Spirometry.
His most cited work include:
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma (1799 citations)
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program (1383 citations)
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. (1306 citations)
What are the main themes of his work throughout his whole career to date?
Eugene R. Bleecker focuses on Asthma, Internal medicine, Immunology, Genetics and COPD.
His Asthma research includes themes of Placebo, Anesthesia, Intensive care medicine and Corticosteroid.
His Placebo study combines topics in areas such as Benralizumab, Clinical endpoint and Adverse effect.
His research in Internal medicine intersects with topics in Gastroenterology and Endocrinology.
He combines subjects such as Single-nucleotide polymorphism and Gene with his study of Immunology.
His research investigates the connection between COPD and topics such as Sputum that intersect with issues in Eosinophil.
He most often published in these fields:
- Asthma (55.95%)
- Internal medicine (37.86%)
- Immunology (29.31%)
What were the highlights of his more recent work (between 2018-2021)?
- Asthma (55.95%)
- Internal medicine (37.86%)
- Immunology (29.31%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Asthma, Internal medicine, Immunology, COPD and Severe asthma.
His biological study spans a wide range of topics, including Genome-wide association study, Exacerbation, Sputum, Corticosteroid and Cohort.
His work carried out in the field of Internal medicine brings together such families of science as Placebo and Cardiology.
His research integrates issues of Expression quantitative trait loci, Gene expression and Bronchoalveolar lavage in his study of Immunology.
His COPD research integrates issues from Genetic variants, Lung and FEV1/FVC ratio.
His work on Benralizumab as part of general Severe asthma research is often related to HSD3B1, thus linking different fields of science.
Between 2018 and 2021, his most popular works were:
- COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids. (158 citations)
- Assembly of a pan-genome from deep sequencing of 910 humans of African descent (141 citations)
- New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries (105 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Asthma
Eugene R. Bleecker mainly focuses on Asthma, Internal medicine, COPD, Severe asthma and Genome-wide association study.
Asthma is a primary field of his research addressed under Immunology.
Eugene R. Bleecker has included themes like Diabetes mellitus, Gene expression and Predictive biomarker in his Immunology study.
The COPD study combines topics in areas such as Pulmonary disease, Spirometry and Lung function.
His Severe asthma study integrates concerns from other disciplines, such as Eosinophil, Exhaled nitric oxide, Guideline, Respiratory system and Asthma severity.
The study incorporates disciplines such as Genetic variation, Genetic association and Genetic admixture in addition to Genome-wide association study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
